RFA
TGTX icon

Reilly Financial Advisors’s TG Therapeutics TGTX Stock Holding History

Reilly Financial Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100
Closed – – 956
2016
Q4 		$0 Hold
100
– – ﹤0.01% 897
2016
Q3 		$1K Hold
100
– – ﹤0.01% 807
2016
Q2 		$1K Hold
100
– – ﹤0.01% 773
2016
Q1 		$1K Hold
100
– – ﹤0.01% 1135
2015
Q4 		$1K Hold
100
– – ﹤0.01% 1141
2015
Q3 		$1K Hold
100
– – ﹤0.01% 1217
2015
Q2 		$2K Buy
+100
New +$1.58K ﹤0.01% 1232

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Reilly Financial Advisors's TGTX Position: Q1 2017 in Review

Reilly Financial Advisors sold out of TG Therapeutics (TGTX) in Q1 2017, closing a stake of 100 shares.

Reilly Financial Advisors first reported a position in TGTX in Q2 2015 and held it in 7 quarters. The position peaked at $2K in Q2 2015. 97 funds tracked by Wall St. Rank hold TGTX as of Q1 2017.

  • Reilly Financial Advisors reported no remaining TG Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Reilly Financial Advisors sold 100 TG Therapeutics shares in Q1 2017.
  • Reilly Financial Advisors first reported a position in TG Therapeutics in Q2 2015 and held it in 7 quarters.
  • Reilly Financial Advisors's TG Therapeutics position peaked at $2K in Q2 2015.
  • 97 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2017.

Based on Reilly Financial Advisors's 13F filing for Q1 2017, filed 18 Apr 2017.